In fact, a small molecule αVβ1 inhibitor, which was able to down-regulate TGFβ-induced signaling, was effective in reducing CCl4-induced hepatic fibrosis in mice [98]. The gene discussed is TGFB1; the disease is Hepatic fibrosis.